Product Code: A06209
Title:
Life Science Analytics Software Market
by Product (Descriptive Analytics, Prescriptive Analytics, and Predictive Analytics), Application (Research & Development, Sales & Marketing Support, Regulatory Compliance, Supply Chain Analytics, and Pharmacovigilance), Delivery Model (On-Premise and Cloud), and End User (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Research Centers and Third-Party Administrators): Global Opportunity Analysis and Industry Forecast, 2020-2027.
The global life science analytics software market size in 2019 was $5.35 billion in 2019, and is expected to reach $16.04 billion by 2027 at a CAGR of 12.3% from 2020 to 2027.The life sciences industry is moving from treatment to preventive scenarios and management of patient's health outcomes. In addition, early detection of disease patterns and strategic target is the key for effective business strategies. Thus, life science companies are demanding for analytics software that is used to transform data into useful insights. In addition, benefits of analytics software in life sciences such as early detection of prescription and treatment patterns, strategizing patient outcomes and achieving better operational quality that drives the intellectual journey of patient centricity further boosts the growth of the global life science analytics software market.
The market is derived completely on the basis of the revenue generated through software license, subscription and maintenance. These are used in research & development, clinical trials, preclinical trials, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance. The major factors driving the growth of the life science analytics software is rise in in prevalence of chronic disease; and pressure to reduce healthcare expenditure and increased demand for improved patient outcomes. In addition, increase in adoption of analytics solutions in clinical trials and sales & marketing applications further boosts the market growth. However, lack of skilled professionals in developing countries and data privacy issues hamper the market growth. On the contrary, emergence of big data analytics to increase R&D productivity is anticipated to provide significant profitable opportunities for manufacturers in the life science analytics software industry.
The life science analytics software market is segmented on the basis of product, application, delivery model, end user and region. By product, it is divided into descriptive analytics, prescriptive analytics and predictive analytics. On the basis of application, it is classified into research & development, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance. The research & development is further segmented into clinical trials and preclinical trials. On the basis of delivery model, it is bifurcated into on-premise and cloud. By end user, it is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers and third-party administrators (TPAS). Region wise, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis along with the current global life science analytics software market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment
The market forecast is studied from 2020 to 2027
The market size and estimations are based on a comprehensive analysis of key developments in the industry
A qualitative analysis based on innovative products facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
KEY MARKET SEGMENTS
By Product
- Descriptive Analytics
- Predictive Analytics
- Prescriptive Analytics
By Application
- Research and Development
- Clinical Trials
- Preclinical Trials
- Sales and Marketing Support
- Regulatory Compliance
- Supply Chain Analytics
- Pharmacovigilance
By Delivery
By End User
- Pharmaceutical and Biotechnology Companies
- Medical Device Companies
- Research Centers
- Third Party Administrators (TPAS)
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- KEY MARKET PLAYERS
- Accenture Plc,
- ArisGlobal LLC,
- Chemical Abstracts Services (ACS)
- Certara, L.P
- Clarivate Analytics Plc.
- Cognizant Technology Solutions Corporation
- Dassault Systemes
- Deloitte Touche Tohmatsu Limited.
- IQVIA Holdings Inc
- Microsoft Corporation
- Oracle Corporation
- TIBCO Software Inc.
- Veeva Systems Inc.
The other players in the value chain include (profiles not included in the report):
- IBM Corporation
- Quintiles Inc
- SAS Institute Inc.
- SCIO Health Analytics
- TAKE Solutions
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key benefits for stakeholders
- 1.3.Key market segments
- 1.4.Research methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- 1.4.4.Primary research
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.2.2.Top winning strategies
- 3.2.3.Top player positioning, 2019
- 3.3.Porter's five forces analysis
- 3.4.Market dynamics
- 3.4.1.Drivers
- 3.4.1.1.Surge in prevalence of chronic disease
- 3.4.1.2.Pressure to reduce healthcare expenditure & increased demand for improved patient outcomes.
- 3.4.1.3.Rise in adoption of analytics solutions in clinical trials and sales & marketing applications
- 3.4.2.Restraints
- 3.4.2.1.Lack of skilled professionals in developing countries
- 3.4.2.2.Data privacy issues
- 3.4.3.Opportunity
- 3.4.3.1.Emergence of big data analytics to increase R&D productivity
CHAPTER 4:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT
- 4.1.Overview
- 4.1.1.Market size and forecast
- 4.2.Descriptive analytics
- 4.2.1.Key market trends, growth factors and opportunities
- 4.2.2.Market size and forecast, by region
- 4.2.3.Market analysis, by country
- 4.3.Predictive Analytics
- 4.3.1.Key market trends, growth factors and opportunities
- 4.3.2.Market size and forecast, by region
- 4.3.3.Market analysis, by country
- 4.4.Prescriptive analytics
- 4.4.1.Key market trends, growth factors and opportunities
- 4.4.2.Market size and forecast, by region
- 4.4.3.Market analysis, by country
CHAPTER 5:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION
- 5.1.Overview
- 5.1.1.Market size and forecast
- 5.2.Research and development
- 5.2.1.Market size and forecast, by type
- 5.2.1.1.Clinical Trials
- 5.2.1.1.1.Market size and forecast
- 5.2.1.2.Preclinical Trials
- 5.2.1.2.1.Market size and forecast
- 5.2.2.Market size and forecast, by region
- 5.2.3.Market analysis, by country
- 5.3.Sales and marketing support
- 5.3.1.Market size and forecast, by region
- 5.3.2.Market analysis, by country
- 5.4.Regulatory compliance
- 5.4.1.Market size and forecast, by region
- 5.4.2.Market analysis, by country
- 5.5.Supply chain analytics
- 5.5.1.Market size and forecast, by region
- 5.5.2.Market analysis, by country
- 5.6.Pharmacovigilance
- 5.6.1.Market size and forecast, by region
- 5.6.2.Market analysis, by country
CHAPTER 6:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL
- 6.1.Overview
- 6.1.1.Market size and forecast
- 6.2.On-premise
- 6.2.1.Market size and forecast, by region
- 6.2.2.Market analysis, by country
- 6.3.Cloud
- 6.3.1.Market size and forecast, by region
- 6.3.2.Market analysis, by country
CHAPTER 7:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET BY END USER
- 7.1.Overview
- 7.1.1.Market size and forecast
- 7.2.Pharmaceutical and biotechnology companies
- 7.2.1.Market size and forecast, by region
- 7.2.2.Market analysis, by country
- 7.3.Medical device companies
- 7.3.1.Market size and forecast, by region
- 7.3.2.Market analysis, by country
- 7.4.Research centers
- 7.4.1.Market size and forecast, by region
- 7.4.2.Market analysis, by country
- 7.5.Third-party administrators
- 7.5.1.Market size and forecast, by region
- 7.5.2.Market analysis, by country
CHAPTER 8:LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION
- 8.1.Overview
- 8.1.1.Market size and forecast
- 8.2.North America
- 8.2.1.Key market trends, growth factors and opportunities
- 8.2.2.North America life science analytics software market, by country
- 8.2.2.1.U.S. life science analytics software market, by product
- 8.2.2.2.U.S life science analytics software market, by application
- 8.2.2.3.U.S. life science analytics software market, by delivery model
- 8.2.2.4.U.S. life science analytics software market, by end user
- 8.2.2.5.Canada life science analytics software market, by product
- 8.2.2.6.Canada life science analytics software market, by application
- 8.2.2.7.Canada life science analytics software market, by delivery model
- 8.2.2.8.Canada life science analytics software market, by end user
- 8.2.2.9.Mexico life science analytics software market, by product
- 8.2.2.10.Mexico life science analytics software market, by application
- 8.2.2.11.Mexico life science analytics software market, by delivery model
- 8.2.2.12.Mexico life science analytics software market, by end user
- 8.2.3.North America life science analytics software market, by product
- 8.2.4.North America life science analytics software market, by application
- 8.2.5.North America life science analytics software market, by delivery model
- 8.2.6.North America life science analytics software market, by end user
- 8.3.Europe
- 8.3.1.Key market trends, growth factors and opportunities
- 8.3.2.Europe life science analytics software market, by country
- 8.3.2.1.UK life science analytics software market, by product
- 8.3.2.2.UK life science analytics software market, by application
- 8.3.2.3.UK life science analytics software market, by delivery model
- 8.3.2.4.UK life science analytics software market, by end user
- 8.3.2.5.Germany life science analytics software market, by product
- 8.3.2.6.Germany life science analytics software market, by application
- 8.3.2.7.Germany life science analytics software market, by delivery model
- 8.3.2.8.Germany life science analytics software market, by end user
- 8.3.2.9.France life science analytics software market, by product
- 8.3.2.10.France life science analytics software market, by application
- 8.3.2.11.France life science analytics software market, by delivery model
- 8.3.2.12.France life science analytics software market, by end user
- 8.3.2.13.Italy life science analytics software market, by product
- 8.3.2.14.Italy life science analytics software market, by application
- 8.3.2.15.Italy life science analytics software market, by delivery model
- 8.3.2.16.Italy life science analytics software market, by end user
- 8.3.2.17.Spain life science analytics software market, by product
- 8.3.2.18.Spain life science analytics software market, by application
- 8.3.2.19.Spain life science analytics software market, by delivery model
- 8.3.2.20.Spain life science analytics software market, by end user
- 8.3.2.21.Rest of Europe life science analytics software market, by product
- 8.3.2.22.Rest of Europe life science analytics software market, by application
- 8.3.2.23.Rest of Europe life science analytics software market, by delivery model
- 8.3.2.24.Rest of Europe life science analytics software market, by end user
- 8.3.3.Europe life science analytics software market, by product
- 8.3.4.Europe life science analytics software market, by application
- 8.3.5.Europe life science analytics software market, by delivery model
- 8.3.6.Europe life science analytics software market, by end user
- 8.4.Asia-pacific
- 8.4.1.Key market trends, growth factors and opportunities
- 8.4.2.Asia-Pacific life science analytics software market, by country
- 8.4.2.1.Japan life science analytics software market, by product
- 8.4.2.2.Japan life science analytics software market, by application
- 8.4.2.3.Japan life science analytics software market, by delivery model
- 8.4.2.4.Japan life science analytics software market, by end user
- 8.4.2.5.China life science analytics software market, by product
- 8.4.2.6.China life science analytics software market, by application
- 8.4.2.7.China life science analytics software market, by delivery model
- 8.4.2.8.China life science analytics software market, by end user
- 8.4.2.9.Australia life science analytics software market, by product
- 8.4.2.10.Australia life science analytics software market, by application
- 8.4.2.11.Australia life science analytics software market, by delivery model.
- 8.4.2.12.Australia life science analytics software market, by end user
- 8.4.2.13.India life science analytics software market, by product
- 8.4.2.14.India life science analytics software market, by application
- 8.4.2.15.India life science analytics software market, by delivery model
- 8.4.2.16.India life science analytics software market, by end user
- 8.4.2.17.Rest of Asia-Pacific life science analytics software market, by product
- 8.4.2.18.Rest of Asia-Pacific life science analytics software market, by application
- 8.4.2.19.Rest of Asia-Pacific life science analytics software market, by delivery model
- 8.4.2.20.Rest of Asia-Pacific life science analytics software market, by end user
- 8.4.3.Asia-Pacific life science analytics software market, by product
- 8.4.4.Asia-Pacific life science analytics software market, by application
- 8.4.5.Asia-Pacific life science analytics software market, by delivery model
- 8.4.6.Asia-Pacific life science analytics software market, by end user
- 8.5.LAMEA
- 8.5.1.Key market trends, growth factors and opportunities
- 8.5.2.LAMEA life science analytics software market, by country
- 8.5.2.1.Brazil life science analytics software market, by product
- 8.5.2.2.Brazil life science analytics software market, by application
- 8.5.2.3.Brazil life science analytics software market, by delivery model
- 8.5.2.4.Brazil life science analytics software market, by end user
- 8.5.2.5.Saudi Arabia life science analytics software market, by product
- 8.5.2.6.Saudi Arabia life science analytics software market, by application
- 8.5.2.7.Saudi Arabia life science analytics software market, by delivery model
- 8.5.2.8.Saudi Arabia life science analytics software market, by end user
- 8.5.2.9.South Africa life science analytics software market, by product
- 8.5.2.10.South Africa life science analytics software market, by application
- 8.5.2.11.South Africa life science analytics software market, by delivery model
- 8.5.2.12.South Africa life science analytics software market, by end user
- 8.5.2.13.Rest of LAMEA life science analytics software market, by product
- 8.5.2.14.Rest of LAMEA life science analytics software market, by application
- 8.5.2.15.Rest of LAMEA life science analytics software market, by delivery model
- 8.5.2.16.Rest of LAMEA life science analytics software market, by end user
- 8.5.3.LAMEA life science analytics software market, by product
- 8.5.4.LAMEA life science analytics software market, by application
- 8.5.5.LAMEA life science analytics software market, by delivery model
- 8.5.6.LAMEA life science analytics software market, by end user
CHAPTER 9:COMPANY PROFILES
- 9.1.ACCENTURE PLC
- 9.1.1.Company overview
- 9.1.2.Company snapshot
- 9.1.3.Operating business segments
- 9.1.4.Product portfolio
- 9.1.5.Business performance
- 9.2.ARISGLOBAL LLC
- 9.2.1.Company overview
- 9.2.2.Company snapshot
- 9.2.3.Operating business segments
- 9.2.4.Product portfolio
- 9.2.5.Key strategic moves and developments
- 9.3.CHEMICAL ABSTRACTS SERVICES (ACS)
- 9.3.1.Company overview
- 9.3.2.Company snapshot
- 9.3.3.Operating business segments
- 9.3.4.Product portfolio
- 9.4.CERTARA, L.P.
- 9.4.1.Company overview
- 9.4.2.Company snapshot
- 9.4.3.Operating business segments
- 9.4.4.Product portfolio
- 9.4.5.Key strategic moves and developments
- 9.5.CLARIVATE ANALYTICS PLC
- 9.5.1.Company overview
- 9.5.2.Company snapshot
- 9.5.3.Operating business segments
- 9.5.4.Product portfolio
- 9.5.5.Business performance
- 9.5.6.Key strategic moves and developments
- 9.6.COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
- 9.6.1.Company overview
- 9.6.2.Company snapshot
- 9.6.3.Operating business segments
- 9.6.4.Product portfolio
- 9.6.5.Business performance
- 9.6.6.Key strategic moves and developments
- 9.7.DASSAULT SYSTEMES
- 9.7.1.Company overview
- 9.7.2.Company snapshot
- 9.7.3.Operating business segments:
- 9.7.4.Product portfolio
- 9.7.5.Business performance
- 9.8.DELOITTE
- 9.8.1.Company overview
- 9.8.2.Company snapshot
- 9.8.3.Operating business segments
- 9.8.4.Product portfolio
- 9.8.5.Business performance
- 9.9.IQVIA HOLDINGS INC
- 9.9.1.Company overview
- 9.9.2.Company snapshot
- 9.9.3.Operating business segments
- 9.9.4.Product portfolio
- 9.9.5.Business performance
- 9.9.6.Key strategic moves and developments
- 9.10.MICROSOFT CORPORATION
- 9.10.1.Company overview
- 9.10.2.Company snapshot
- 9.10.3.Operating business segments
- 9.10.4.Product portfolio
- 9.10.5.Business performance
- 9.11.ORACLE CORPORATION
- 9.11.1.Company overview
- 9.11.2.Company snapshot
- 9.11.3.Operating business segments
- 9.11.4.Product portfolio
- 9.11.5.Business performance
- 9.11.6.Key strategic moves and developments
- 9.12.TIBCO SOFTWARE INC
- 9.12.1.Company overview
- 9.12.2.Operating business segments
- 9.12.3.Product portfolio
- 9.13.VEEVA SYSTEMS INC
- 9.13.1.Company overview
- 9.13.2.Company snapshot
- 9.13.3.Operating business segments
- 9.13.4.Product portfolio
- 9.13.5.Business performance
比較リスト
